anti cd69 Search Results


93
Miltenyi Biotec anti cd69 viogreen
Anti Cd69 Viogreen, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69/pm30728330-350-28-31?v=Miltenyi+Biotec
Average 93 stars, based on 1 article reviews
anti cd69 viogreen - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Miltenyi Biotec anti cd69 pe
Anti Cd69 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69/pm34853379-270-38-41?v=Miltenyi+Biotec
Average 94 stars, based on 1 article reviews
anti cd69 pe - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Miltenyi Biotec cd69 vioblue
Cd69 Vioblue, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69/10__3389_slash_fimmu__2026__1844781-143-30-32?v=Miltenyi+Biotec
Average 93 stars, based on 1 article reviews
cd69 vioblue - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Miltenyi Biotec 130 095 212 custom anti human cd69 fitc miltenyi biotec
130 095 212 Custom Anti Human Cd69 Fitc Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69/pm41709452-498-238-242?v=Miltenyi+Biotec
Average 94 stars, based on 1 article reviews
130 095 212 custom anti human cd69 fitc miltenyi biotec - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

95
Novus Biologicals cd69
A . Blood and tonsil mononuclear cells pregated on CD8 T-cells by flow cytometry for perforin and granzyme B. B . Expression intensity of <t>CD69,</t> CD103, CXCR5, CD127, PD-1, Perforin and granzyme B in multidimensional tSNE space for CD8 + T-cells, gated from total CD45 + T-cells. Peripheral blood (blue), tonsil tissue (orange). C . Percentage of blood and tonsil CD8 + T-cells expressing indicated markers. D . Schematic of protocol for isolate of HIV + CD8 + T cells from peripheral blood and tonsil tissue by scRNA-seq using Seq-Well v3 (top). UMAP of CD8 + T cells coloured by tissue source (bottom). E . Heatmap of z-scored gene expression of CD8 + T cells illustrating differentially expressed genes between blood and tonsil. Selective specifically expressed genes are marked alongside. F . Violin plots showing selected genes for cytolytic, transcription factors, tissue-resident memory and immune suppressive markers, expressed in CD8 + T cells. FDR-adjusted p<0.05; full results can be found in Supplementary Table S1. G . Fluorescent immunohistochemistry of whole tonsil section (left) from HIV uninfected donor shown by CD8, CD4 and merged panels (middle) with quantification using 10 unrelated areas identified outside follicles (outside GCs) and within follicular germinal centers ( inside GCs). P-values by Kruskal-Wallis multi comparisons.
Cd69, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69/bio_rxiv__2021__11__04__467061-202-44-47?v=Novus+Biologicals
Average 95 stars, based on 1 article reviews
cd69 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

88
Bio-Rad hamster anti mouse cd69
A . Blood and tonsil mononuclear cells pregated on CD8 T-cells by flow cytometry for perforin and granzyme B. B . Expression intensity of <t>CD69,</t> CD103, CXCR5, CD127, PD-1, Perforin and granzyme B in multidimensional tSNE space for CD8 + T-cells, gated from total CD45 + T-cells. Peripheral blood (blue), tonsil tissue (orange). C . Percentage of blood and tonsil CD8 + T-cells expressing indicated markers. D . Schematic of protocol for isolate of HIV + CD8 + T cells from peripheral blood and tonsil tissue by scRNA-seq using Seq-Well v3 (top). UMAP of CD8 + T cells coloured by tissue source (bottom). E . Heatmap of z-scored gene expression of CD8 + T cells illustrating differentially expressed genes between blood and tonsil. Selective specifically expressed genes are marked alongside. F . Violin plots showing selected genes for cytolytic, transcription factors, tissue-resident memory and immune suppressive markers, expressed in CD8 + T cells. FDR-adjusted p<0.05; full results can be found in Supplementary Table S1. G . Fluorescent immunohistochemistry of whole tonsil section (left) from HIV uninfected donor shown by CD8, CD4 and merged panels (middle) with quantification using 10 unrelated areas identified outside follicles (outside GCs) and within follicular germinal centers ( inside GCs). P-values by Kruskal-Wallis multi comparisons.
Hamster Anti Mouse Cd69, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69/pmc00369208-119-1-9?v=Bio-Rad
Average 88 stars, based on 1 article reviews
hamster anti mouse cd69 - by Bioz Stars, 2026-08
88/100 stars
  Buy from Supplier

93
Elabscience Biotechnology elabscience cat e ab f1138h
A . Blood and tonsil mononuclear cells pregated on CD8 T-cells by flow cytometry for perforin and granzyme B. B . Expression intensity of <t>CD69,</t> CD103, CXCR5, CD127, PD-1, Perforin and granzyme B in multidimensional tSNE space for CD8 + T-cells, gated from total CD45 + T-cells. Peripheral blood (blue), tonsil tissue (orange). C . Percentage of blood and tonsil CD8 + T-cells expressing indicated markers. D . Schematic of protocol for isolate of HIV + CD8 + T cells from peripheral blood and tonsil tissue by scRNA-seq using Seq-Well v3 (top). UMAP of CD8 + T cells coloured by tissue source (bottom). E . Heatmap of z-scored gene expression of CD8 + T cells illustrating differentially expressed genes between blood and tonsil. Selective specifically expressed genes are marked alongside. F . Violin plots showing selected genes for cytolytic, transcription factors, tissue-resident memory and immune suppressive markers, expressed in CD8 + T cells. FDR-adjusted p<0.05; full results can be found in Supplementary Table S1. G . Fluorescent immunohistochemistry of whole tonsil section (left) from HIV uninfected donor shown by CD8, CD4 and merged panels (middle) with quantification using 10 unrelated areas identified outside follicles (outside GCs) and within follicular germinal centers ( inside GCs). P-values by Kruskal-Wallis multi comparisons.
Elabscience Cat E Ab F1138h, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69/10__2147_slash_jir__s473068-77-104-104?v=Elabscience+Biotechnology
Average 93 stars, based on 1 article reviews
elabscience cat e ab f1138h - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Bio-Rad isotypic negative
A . Blood and tonsil mononuclear cells pregated on CD8 T-cells by flow cytometry for perforin and granzyme B. B . Expression intensity of <t>CD69,</t> CD103, CXCR5, CD127, PD-1, Perforin and granzyme B in multidimensional tSNE space for CD8 + T-cells, gated from total CD45 + T-cells. Peripheral blood (blue), tonsil tissue (orange). C . Percentage of blood and tonsil CD8 + T-cells expressing indicated markers. D . Schematic of protocol for isolate of HIV + CD8 + T cells from peripheral blood and tonsil tissue by scRNA-seq using Seq-Well v3 (top). UMAP of CD8 + T cells coloured by tissue source (bottom). E . Heatmap of z-scored gene expression of CD8 + T cells illustrating differentially expressed genes between blood and tonsil. Selective specifically expressed genes are marked alongside. F . Violin plots showing selected genes for cytolytic, transcription factors, tissue-resident memory and immune suppressive markers, expressed in CD8 + T cells. FDR-adjusted p<0.05; full results can be found in Supplementary Table S1. G . Fluorescent immunohistochemistry of whole tonsil section (left) from HIV uninfected donor shown by CD8, CD4 and merged panels (middle) with quantification using 10 unrelated areas identified outside follicles (outside GCs) and within follicular germinal centers ( inside GCs). P-values by Kruskal-Wallis multi comparisons.
Isotypic Negative, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69/pmc09878989-51-12-21?v=Bio-Rad
Average 93 stars, based on 1 article reviews
isotypic negative - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Elabscience Biotechnology pe anti mouse cd69
A . Blood and tonsil mononuclear cells pregated on CD8 T-cells by flow cytometry for perforin and granzyme B. B . Expression intensity of <t>CD69,</t> CD103, CXCR5, CD127, PD-1, Perforin and granzyme B in multidimensional tSNE space for CD8 + T-cells, gated from total CD45 + T-cells. Peripheral blood (blue), tonsil tissue (orange). C . Percentage of blood and tonsil CD8 + T-cells expressing indicated markers. D . Schematic of protocol for isolate of HIV + CD8 + T cells from peripheral blood and tonsil tissue by scRNA-seq using Seq-Well v3 (top). UMAP of CD8 + T cells coloured by tissue source (bottom). E . Heatmap of z-scored gene expression of CD8 + T cells illustrating differentially expressed genes between blood and tonsil. Selective specifically expressed genes are marked alongside. F . Violin plots showing selected genes for cytolytic, transcription factors, tissue-resident memory and immune suppressive markers, expressed in CD8 + T cells. FDR-adjusted p<0.05; full results can be found in Supplementary Table S1. G . Fluorescent immunohistochemistry of whole tonsil section (left) from HIV uninfected donor shown by CD8, CD4 and merged panels (middle) with quantification using 10 unrelated areas identified outside follicles (outside GCs) and within follicular germinal centers ( inside GCs). P-values by Kruskal-Wallis multi comparisons.
Pe Anti Mouse Cd69, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69/10__26599_slash_nr__2025__94908285-404-18-53?v=Elabscience+Biotechnology
Average 94 stars, based on 1 article reviews
pe anti mouse cd69 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Cytek Biosciences anti mouse cd69 apc
A . Blood and tonsil mononuclear cells pregated on CD8 T-cells by flow cytometry for perforin and granzyme B. B . Expression intensity of <t>CD69,</t> CD103, CXCR5, CD127, PD-1, Perforin and granzyme B in multidimensional tSNE space for CD8 + T-cells, gated from total CD45 + T-cells. Peripheral blood (blue), tonsil tissue (orange). C . Percentage of blood and tonsil CD8 + T-cells expressing indicated markers. D . Schematic of protocol for isolate of HIV + CD8 + T cells from peripheral blood and tonsil tissue by scRNA-seq using Seq-Well v3 (top). UMAP of CD8 + T cells coloured by tissue source (bottom). E . Heatmap of z-scored gene expression of CD8 + T cells illustrating differentially expressed genes between blood and tonsil. Selective specifically expressed genes are marked alongside. F . Violin plots showing selected genes for cytolytic, transcription factors, tissue-resident memory and immune suppressive markers, expressed in CD8 + T cells. FDR-adjusted p<0.05; full results can be found in Supplementary Table S1. G . Fluorescent immunohistochemistry of whole tonsil section (left) from HIV uninfected donor shown by CD8, CD4 and merged panels (middle) with quantification using 10 unrelated areas identified outside follicles (outside GCs) and within follicular germinal centers ( inside GCs). P-values by Kruskal-Wallis multi comparisons.
Anti Mouse Cd69 Apc, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69/pm41826949-111-81-86?v=Cytek+Biosciences
Average 93 stars, based on 1 article reviews
anti mouse cd69 apc - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Cytek Biosciences anti cd69 pe cy7
(A) Mice were immunized i.n. with OVA-containing formulations on d0 and lungs and spleens were analyzed on d30 or d60 via tetramer and surface marker staining. CXCR3 was used as a marker of AW residence; CD103 and <t>CD69</t> were used as markers of tissue residency. (B-E) Number (#) and frequency (%) of Tet+ CD8+ T cells in (B) AW, (C) IST, (D) MV, and (E) spleen were enumerated on d30 after i.n. administration of OVA-NP/CpG, OVA-NP, or OVA+CpG. (F-I) Number (#) and frequency (%) of Tet+ CD8+ T cells in (F) AW, (G) IST, (H) MV, and (I) spleen were enumerated on d60 after i.n. administration of OVA-NP/CpG, OVA-NP, or OVA+CpG. (J) Flow cytometry was used to quantify Tet+ CD8+ T cells expressing TRM markers (CD103, CD69) in the airway (CXCR3hi) and lung interstitium (CXCR3lo). (K-L) Number (#) of Tet+ CD8+ T cells expressing CD69±CD103 in AW were enumerated on (K) d30 or (L) d60 after immunization. (M-N) Number (#) of Tet+ CD8+ T cells expressing CD69±CD103 in IST were enumerated on (M) d30 or (N) d60 after immunization. Data are mean ± SEM and representative of two to four independent experiments, with n = 5–6 per group. Immunization dose: 25 μg NP, 7.5 μg OVA, 1.4 μg. CpG Limit of detection: 1 cell (AW), 5 cells (IST/MV), 25 cells (spleen). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, by (B-I) ordinary one-way ANOVA or (K-N) ordinary two-way ANOVA with Tukey’s multiple comparisons test. ns, not significant. Statistical comparisons are shown for OVA-NP/CpG only.
Anti Cd69 Pe Cy7, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69/pmc06832804-659-19-22?v=Cytek+Biosciences
Average 93 stars, based on 1 article reviews
anti cd69 pe cy7 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

91
Proteintech cd69 pe pe 65105
(A) Mice were immunized i.n. with OVA-containing formulations on d0 and lungs and spleens were analyzed on d30 or d60 via tetramer and surface marker staining. CXCR3 was used as a marker of AW residence; CD103 and <t>CD69</t> were used as markers of tissue residency. (B-E) Number (#) and frequency (%) of Tet+ CD8+ T cells in (B) AW, (C) IST, (D) MV, and (E) spleen were enumerated on d30 after i.n. administration of OVA-NP/CpG, OVA-NP, or OVA+CpG. (F-I) Number (#) and frequency (%) of Tet+ CD8+ T cells in (F) AW, (G) IST, (H) MV, and (I) spleen were enumerated on d60 after i.n. administration of OVA-NP/CpG, OVA-NP, or OVA+CpG. (J) Flow cytometry was used to quantify Tet+ CD8+ T cells expressing TRM markers (CD103, CD69) in the airway (CXCR3hi) and lung interstitium (CXCR3lo). (K-L) Number (#) of Tet+ CD8+ T cells expressing CD69±CD103 in AW were enumerated on (K) d30 or (L) d60 after immunization. (M-N) Number (#) of Tet+ CD8+ T cells expressing CD69±CD103 in IST were enumerated on (M) d30 or (N) d60 after immunization. Data are mean ± SEM and representative of two to four independent experiments, with n = 5–6 per group. Immunization dose: 25 μg NP, 7.5 μg OVA, 1.4 μg. CpG Limit of detection: 1 cell (AW), 5 cells (IST/MV), 25 cells (spleen). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, by (B-I) ordinary one-way ANOVA or (K-N) ordinary two-way ANOVA with Tukey’s multiple comparisons test. ns, not significant. Statistical comparisons are shown for OVA-NP/CpG only.
Cd69 Pe Pe 65105, supplied by Proteintech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd69/pmc10132258__SC___014___D2SC06036A___s001-34-0-15?v=Proteintech
Average 91 stars, based on 1 article reviews
cd69 pe pe 65105 - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

Image Search Results


A . Blood and tonsil mononuclear cells pregated on CD8 T-cells by flow cytometry for perforin and granzyme B. B . Expression intensity of CD69, CD103, CXCR5, CD127, PD-1, Perforin and granzyme B in multidimensional tSNE space for CD8 + T-cells, gated from total CD45 + T-cells. Peripheral blood (blue), tonsil tissue (orange). C . Percentage of blood and tonsil CD8 + T-cells expressing indicated markers. D . Schematic of protocol for isolate of HIV + CD8 + T cells from peripheral blood and tonsil tissue by scRNA-seq using Seq-Well v3 (top). UMAP of CD8 + T cells coloured by tissue source (bottom). E . Heatmap of z-scored gene expression of CD8 + T cells illustrating differentially expressed genes between blood and tonsil. Selective specifically expressed genes are marked alongside. F . Violin plots showing selected genes for cytolytic, transcription factors, tissue-resident memory and immune suppressive markers, expressed in CD8 + T cells. FDR-adjusted p<0.05; full results can be found in Supplementary Table S1. G . Fluorescent immunohistochemistry of whole tonsil section (left) from HIV uninfected donor shown by CD8, CD4 and merged panels (middle) with quantification using 10 unrelated areas identified outside follicles (outside GCs) and within follicular germinal centers ( inside GCs). P-values by Kruskal-Wallis multi comparisons.

Journal: bioRxiv

Article Title: HIV-specific CD8 + T-cells in tonsils express exhaustive T RM -like signatures

doi: 10.1101/2021.11.04.467061

Figure Lengend Snippet: A . Blood and tonsil mononuclear cells pregated on CD8 T-cells by flow cytometry for perforin and granzyme B. B . Expression intensity of CD69, CD103, CXCR5, CD127, PD-1, Perforin and granzyme B in multidimensional tSNE space for CD8 + T-cells, gated from total CD45 + T-cells. Peripheral blood (blue), tonsil tissue (orange). C . Percentage of blood and tonsil CD8 + T-cells expressing indicated markers. D . Schematic of protocol for isolate of HIV + CD8 + T cells from peripheral blood and tonsil tissue by scRNA-seq using Seq-Well v3 (top). UMAP of CD8 + T cells coloured by tissue source (bottom). E . Heatmap of z-scored gene expression of CD8 + T cells illustrating differentially expressed genes between blood and tonsil. Selective specifically expressed genes are marked alongside. F . Violin plots showing selected genes for cytolytic, transcription factors, tissue-resident memory and immune suppressive markers, expressed in CD8 + T cells. FDR-adjusted p<0.05; full results can be found in Supplementary Table S1. G . Fluorescent immunohistochemistry of whole tonsil section (left) from HIV uninfected donor shown by CD8, CD4 and merged panels (middle) with quantification using 10 unrelated areas identified outside follicles (outside GCs) and within follicular germinal centers ( inside GCs). P-values by Kruskal-Wallis multi comparisons.

Article Snippet: Exactly 4μm sections were cut, deparaffinized and stained with the following unlabelled primary antibodies: CD8 (clone: C8/144B, Dako), CD4 (clone: 4B12, Dako), p24 (clone: Kal-1, Dako), CXCR5 (clone: MU5UBEE, Thermofisher Scientific), Granzyme B (clone: 23 H8L20, Thermofisher Scientific), CD103 (clone: NBP1-88142, Novus Biologicals) and CD69 (clone: 15B5G2, Novus Biologicals).

Techniques: Flow Cytometry, Expressing, Gene Expression, Immunohistochemistry

A . Percentage of blood (circles) and tonsil (triangles) CD8 + T cells expressing CD69, CD103, CXCR5, CD27, CD127, PD-1, granzyme B and perforin markers between HIV − and HIV + . Red data point indicates viremic (detectable HIV RNA) and red/black data point indicates suppressed (undetectable HIV RNA). P-values calculated using ordinary one-way ANOVA with horizontal bars representing median values with the level of significance indicated with p-value. B . Representative FACS plot of CD8 + T-cells from HIV-(grey triangles) and HIV + (red triangles includes both ART suppressed and viremic individuals) tonsils for co-expression of CD69/CD103 and PD-1/CD127 with cumulative data shown with horizontal bars representing median values and p-values by Kruskal-wallis multiple comparisons. C . CD8, CD69, CD103 fluorescent immunohistochemistry of whole tonsil sections zoomed in at individual GCs for three independent donors from HIV − (left), HIV + ART + (middle) and HIV + ART − (right) with individuals markers shown. D . Same as in C but for CD8, HIV-p24 and PD-1.

Journal: bioRxiv

Article Title: HIV-specific CD8 + T-cells in tonsils express exhaustive T RM -like signatures

doi: 10.1101/2021.11.04.467061

Figure Lengend Snippet: A . Percentage of blood (circles) and tonsil (triangles) CD8 + T cells expressing CD69, CD103, CXCR5, CD27, CD127, PD-1, granzyme B and perforin markers between HIV − and HIV + . Red data point indicates viremic (detectable HIV RNA) and red/black data point indicates suppressed (undetectable HIV RNA). P-values calculated using ordinary one-way ANOVA with horizontal bars representing median values with the level of significance indicated with p-value. B . Representative FACS plot of CD8 + T-cells from HIV-(grey triangles) and HIV + (red triangles includes both ART suppressed and viremic individuals) tonsils for co-expression of CD69/CD103 and PD-1/CD127 with cumulative data shown with horizontal bars representing median values and p-values by Kruskal-wallis multiple comparisons. C . CD8, CD69, CD103 fluorescent immunohistochemistry of whole tonsil sections zoomed in at individual GCs for three independent donors from HIV − (left), HIV + ART + (middle) and HIV + ART − (right) with individuals markers shown. D . Same as in C but for CD8, HIV-p24 and PD-1.

Article Snippet: Exactly 4μm sections were cut, deparaffinized and stained with the following unlabelled primary antibodies: CD8 (clone: C8/144B, Dako), CD4 (clone: 4B12, Dako), p24 (clone: Kal-1, Dako), CXCR5 (clone: MU5UBEE, Thermofisher Scientific), Granzyme B (clone: 23 H8L20, Thermofisher Scientific), CD103 (clone: NBP1-88142, Novus Biologicals) and CD69 (clone: 15B5G2, Novus Biologicals).

Techniques: Expressing, Immunohistochemistry

A . Representative FACS plot of the gating strategy of CD8 + T-cells from tonsil cells to detect naïve, T N (CCR7 + CD45RA + ), central memory (T CM , CCR7 + CD45RA − ), effector memory (T EM , CCR7 − CD45RA − ) and T EMRA (CCR7 − CD45RA + ). B . Different memory subset distribution within blood and tonsil CD8 + T-cells for central memory, T CM (blue), Effector memory, T EM (red), transitional, T EMRA (orange), T Naive (grey) with cumulative memory subset distribution of CD8 + T cells for blood (circles, left) and tonsil (triangles, right). C . Distribution of blood central memory (T CM ), transitional memory (T EMRA ), effector memory (T EM ) and naïve subsets within CD127, CD69, PD-1, perforin and granzyme B expressing CD8 + T-cells cumulative for all study participants in HIV − (grey) and HIV + (red). D . Same as in C but showing data from tonsil CD8 + T-cells. P-values calculated using ordinary one-way ANOVA with horizontal bars representing median values with the level of significance indicated above. E . The frequency of CD103, CD69, CD127, perforin, and granzyme B (Granz B) cells measured on PD-1 + (left) and PD-1 − (right) CD8 + T-cells from blood in HIV + (red) and HIV − (grey) individuals. F . Same as in E but showing data from tonsil CD8 + T-cells. P-values calculated using Paired Student’s t test. Horizontal bars represent median values.

Journal: bioRxiv

Article Title: HIV-specific CD8 + T-cells in tonsils express exhaustive T RM -like signatures

doi: 10.1101/2021.11.04.467061

Figure Lengend Snippet: A . Representative FACS plot of the gating strategy of CD8 + T-cells from tonsil cells to detect naïve, T N (CCR7 + CD45RA + ), central memory (T CM , CCR7 + CD45RA − ), effector memory (T EM , CCR7 − CD45RA − ) and T EMRA (CCR7 − CD45RA + ). B . Different memory subset distribution within blood and tonsil CD8 + T-cells for central memory, T CM (blue), Effector memory, T EM (red), transitional, T EMRA (orange), T Naive (grey) with cumulative memory subset distribution of CD8 + T cells for blood (circles, left) and tonsil (triangles, right). C . Distribution of blood central memory (T CM ), transitional memory (T EMRA ), effector memory (T EM ) and naïve subsets within CD127, CD69, PD-1, perforin and granzyme B expressing CD8 + T-cells cumulative for all study participants in HIV − (grey) and HIV + (red). D . Same as in C but showing data from tonsil CD8 + T-cells. P-values calculated using ordinary one-way ANOVA with horizontal bars representing median values with the level of significance indicated above. E . The frequency of CD103, CD69, CD127, perforin, and granzyme B (Granz B) cells measured on PD-1 + (left) and PD-1 − (right) CD8 + T-cells from blood in HIV + (red) and HIV − (grey) individuals. F . Same as in E but showing data from tonsil CD8 + T-cells. P-values calculated using Paired Student’s t test. Horizontal bars represent median values.

Article Snippet: Exactly 4μm sections were cut, deparaffinized and stained with the following unlabelled primary antibodies: CD8 (clone: C8/144B, Dako), CD4 (clone: 4B12, Dako), p24 (clone: Kal-1, Dako), CXCR5 (clone: MU5UBEE, Thermofisher Scientific), Granzyme B (clone: 23 H8L20, Thermofisher Scientific), CD103 (clone: NBP1-88142, Novus Biologicals) and CD69 (clone: 15B5G2, Novus Biologicals).

Techniques: Expressing

A . Representative flow plots showing CMV-(top) and HIV-specific (bottom) tetramer stains of blood (left) and tonsil tissue (right) from the same participant. B . Heat map showing expression frequencies for the indicated markers among CD8 + T cells from CMV tetramer and HIV tetramer specific CD8 + T-cells in blood (top) and tonsil (bottom) gated CD8 + T-cells with frequencies for each tetramer population indicated in the bar below from blue (0%) to red (100%). C . Frequencies of CD69, CD103, PD-1 and CD127 from HIV-, CMV-, and non-specific (‘CD8’) CD8 + T-cells within blood (left) and tonsil (right) tissue. P-values calculated using ordinary one-way ANOVA with horizontal bars representing median values with the level of significance indicated above.

Journal: bioRxiv

Article Title: HIV-specific CD8 + T-cells in tonsils express exhaustive T RM -like signatures

doi: 10.1101/2021.11.04.467061

Figure Lengend Snippet: A . Representative flow plots showing CMV-(top) and HIV-specific (bottom) tetramer stains of blood (left) and tonsil tissue (right) from the same participant. B . Heat map showing expression frequencies for the indicated markers among CD8 + T cells from CMV tetramer and HIV tetramer specific CD8 + T-cells in blood (top) and tonsil (bottom) gated CD8 + T-cells with frequencies for each tetramer population indicated in the bar below from blue (0%) to red (100%). C . Frequencies of CD69, CD103, PD-1 and CD127 from HIV-, CMV-, and non-specific (‘CD8’) CD8 + T-cells within blood (left) and tonsil (right) tissue. P-values calculated using ordinary one-way ANOVA with horizontal bars representing median values with the level of significance indicated above.

Article Snippet: Exactly 4μm sections were cut, deparaffinized and stained with the following unlabelled primary antibodies: CD8 (clone: C8/144B, Dako), CD4 (clone: 4B12, Dako), p24 (clone: Kal-1, Dako), CXCR5 (clone: MU5UBEE, Thermofisher Scientific), Granzyme B (clone: 23 H8L20, Thermofisher Scientific), CD103 (clone: NBP1-88142, Novus Biologicals) and CD69 (clone: 15B5G2, Novus Biologicals).

Techniques: Expressing

A . Workflow of single-cell RNA sequencing from HIV infected tonsil tissue isolated CD8 + T-cells pre-sorted on HIV-, CMV- and ‘non-specific’ CD8 + T-cells from HIV infected participants indicated in Table S2. B . Dimensionality reduction using tSNE on scRNA-Seq cells coloured by Louvain cluster (top), participant ID (middle), and tetramer specificity (bottom). C . Heatmap of z-scored gene expression of top differentially expressed genes (t-test) between Louvain clusters from scRNA-seq data with cells grouped by Louvain cluster, genes grouped by hierarchical clustering (full gene lists in supplemental Table S3). D . Gene set enrichment scores for each of the 4 Louvain clusters (0-3) shown for ‘ T RM ’ , ‘Exhaustion’ , ‘proliferation’ and ‘activation’ [ , ] published gene lists. E . Heatmaps of z-scored gene expression of top differentially expressed genes (t-test) between single cells with high and low normalized MFI values of CD69, CD103, PD-1 and CD127. Selected genes labelled in plot, full gene lists in Table S4-S5. F . Gene lists from (E) scored against the published gene lists as indicated in D.

Journal: bioRxiv

Article Title: HIV-specific CD8 + T-cells in tonsils express exhaustive T RM -like signatures

doi: 10.1101/2021.11.04.467061

Figure Lengend Snippet: A . Workflow of single-cell RNA sequencing from HIV infected tonsil tissue isolated CD8 + T-cells pre-sorted on HIV-, CMV- and ‘non-specific’ CD8 + T-cells from HIV infected participants indicated in Table S2. B . Dimensionality reduction using tSNE on scRNA-Seq cells coloured by Louvain cluster (top), participant ID (middle), and tetramer specificity (bottom). C . Heatmap of z-scored gene expression of top differentially expressed genes (t-test) between Louvain clusters from scRNA-seq data with cells grouped by Louvain cluster, genes grouped by hierarchical clustering (full gene lists in supplemental Table S3). D . Gene set enrichment scores for each of the 4 Louvain clusters (0-3) shown for ‘ T RM ’ , ‘Exhaustion’ , ‘proliferation’ and ‘activation’ [ , ] published gene lists. E . Heatmaps of z-scored gene expression of top differentially expressed genes (t-test) between single cells with high and low normalized MFI values of CD69, CD103, PD-1 and CD127. Selected genes labelled in plot, full gene lists in Table S4-S5. F . Gene lists from (E) scored against the published gene lists as indicated in D.

Article Snippet: Exactly 4μm sections were cut, deparaffinized and stained with the following unlabelled primary antibodies: CD8 (clone: C8/144B, Dako), CD4 (clone: 4B12, Dako), p24 (clone: Kal-1, Dako), CXCR5 (clone: MU5UBEE, Thermofisher Scientific), Granzyme B (clone: 23 H8L20, Thermofisher Scientific), CD103 (clone: NBP1-88142, Novus Biologicals) and CD69 (clone: 15B5G2, Novus Biologicals).

Techniques: RNA Sequencing, Infection, Isolation, Gene Expression, Activation Assay

(A) Mice were immunized i.n. with OVA-containing formulations on d0 and lungs and spleens were analyzed on d30 or d60 via tetramer and surface marker staining. CXCR3 was used as a marker of AW residence; CD103 and CD69 were used as markers of tissue residency. (B-E) Number (#) and frequency (%) of Tet+ CD8+ T cells in (B) AW, (C) IST, (D) MV, and (E) spleen were enumerated on d30 after i.n. administration of OVA-NP/CpG, OVA-NP, or OVA+CpG. (F-I) Number (#) and frequency (%) of Tet+ CD8+ T cells in (F) AW, (G) IST, (H) MV, and (I) spleen were enumerated on d60 after i.n. administration of OVA-NP/CpG, OVA-NP, or OVA+CpG. (J) Flow cytometry was used to quantify Tet+ CD8+ T cells expressing TRM markers (CD103, CD69) in the airway (CXCR3hi) and lung interstitium (CXCR3lo). (K-L) Number (#) of Tet+ CD8+ T cells expressing CD69±CD103 in AW were enumerated on (K) d30 or (L) d60 after immunization. (M-N) Number (#) of Tet+ CD8+ T cells expressing CD69±CD103 in IST were enumerated on (M) d30 or (N) d60 after immunization. Data are mean ± SEM and representative of two to four independent experiments, with n = 5–6 per group. Immunization dose: 25 μg NP, 7.5 μg OVA, 1.4 μg. CpG Limit of detection: 1 cell (AW), 5 cells (IST/MV), 25 cells (spleen). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, by (B-I) ordinary one-way ANOVA or (K-N) ordinary two-way ANOVA with Tukey’s multiple comparisons test. ns, not significant. Statistical comparisons are shown for OVA-NP/CpG only.

Journal: ACS nano

Article Title: Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8 + Lung-Resident Memory T Cells

doi: 10.1021/acsnano.9b00326

Figure Lengend Snippet: (A) Mice were immunized i.n. with OVA-containing formulations on d0 and lungs and spleens were analyzed on d30 or d60 via tetramer and surface marker staining. CXCR3 was used as a marker of AW residence; CD103 and CD69 were used as markers of tissue residency. (B-E) Number (#) and frequency (%) of Tet+ CD8+ T cells in (B) AW, (C) IST, (D) MV, and (E) spleen were enumerated on d30 after i.n. administration of OVA-NP/CpG, OVA-NP, or OVA+CpG. (F-I) Number (#) and frequency (%) of Tet+ CD8+ T cells in (F) AW, (G) IST, (H) MV, and (I) spleen were enumerated on d60 after i.n. administration of OVA-NP/CpG, OVA-NP, or OVA+CpG. (J) Flow cytometry was used to quantify Tet+ CD8+ T cells expressing TRM markers (CD103, CD69) in the airway (CXCR3hi) and lung interstitium (CXCR3lo). (K-L) Number (#) of Tet+ CD8+ T cells expressing CD69±CD103 in AW were enumerated on (K) d30 or (L) d60 after immunization. (M-N) Number (#) of Tet+ CD8+ T cells expressing CD69±CD103 in IST were enumerated on (M) d30 or (N) d60 after immunization. Data are mean ± SEM and representative of two to four independent experiments, with n = 5–6 per group. Immunization dose: 25 μg NP, 7.5 μg OVA, 1.4 μg. CpG Limit of detection: 1 cell (AW), 5 cells (IST/MV), 25 cells (spleen). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, by (B-I) ordinary one-way ANOVA or (K-N) ordinary two-way ANOVA with Tukey’s multiple comparisons test. ns, not significant. Statistical comparisons are shown for OVA-NP/CpG only.

Article Snippet: In experiments evaluating tissue-resident memory markers on d30 and d60, cells from lungs and spleens were also stained with anti-CD69-PE/Cy7 (clone H1.2F3; Tonbo), anti-CD103-Brilliant Violet 510 (clone 2E7; BioLegend), and anti-CXCR3-PerCP/Cy5.5 (clone CXCR3–173; BioLegend).

Techniques: Marker, Staining, Flow Cytometry, Expressing

(A) Mice were immunized i.n. with Flu-containing formulations on d0 and lungs and spleens were analyzed on d30 or d60 via Tet and surface marker staining. CXCR3 was used as a marker of AW residence; CD103 and CD69 were used as markers of tissue residency. (B-E) Number (#) and frequency (%) of Tet+ CD8+ T cells in (B) AW, (C) IST, (D) MV, and (E) spleen were enumerated on d30 after i.n. administration of Flu-NP/CpG, Flu-NP, or Flu+CpG. (F-I) Number (#) and frequency (%) of Tet+ CD8+ T cells in (F) AW, (G) IST, (H) MV, and (I) spleen were enumerated on d60 after i.n. administration of Flu-NP/CpG, Flu-NP, or Flu+CpG. (J-M) Number (#) of Tet+ CD8+ T cells expressing CD69±CD103 in AW were enumerated on (J) d30 or (K) d60 after immunization. (L-M) Number (#) of Tet+ CD8+ T cells expressing CD69±CD103 in IST were enumerated on (L) d30 or (M) d60 after immunization. Data are mean ± SEM, with n = 3–6 per group, and representative of two independent experiments. Immunization dose: 25 μg NP, 9.5 μg Flu, 1.4 μg CpG. Limit of detection: 1 cell (AW), 5 cells (IST/MV), 25 cells (spleen). *p<0.05, **p<0.01, ***p<0.001, by (B-I) ordinary one-way ANOVA or (J-M) ordinary two-way ANOVA with Tukey’s multiple comparisons test. ns, not significant.

Journal: ACS nano

Article Title: Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8 + Lung-Resident Memory T Cells

doi: 10.1021/acsnano.9b00326

Figure Lengend Snippet: (A) Mice were immunized i.n. with Flu-containing formulations on d0 and lungs and spleens were analyzed on d30 or d60 via Tet and surface marker staining. CXCR3 was used as a marker of AW residence; CD103 and CD69 were used as markers of tissue residency. (B-E) Number (#) and frequency (%) of Tet+ CD8+ T cells in (B) AW, (C) IST, (D) MV, and (E) spleen were enumerated on d30 after i.n. administration of Flu-NP/CpG, Flu-NP, or Flu+CpG. (F-I) Number (#) and frequency (%) of Tet+ CD8+ T cells in (F) AW, (G) IST, (H) MV, and (I) spleen were enumerated on d60 after i.n. administration of Flu-NP/CpG, Flu-NP, or Flu+CpG. (J-M) Number (#) of Tet+ CD8+ T cells expressing CD69±CD103 in AW were enumerated on (J) d30 or (K) d60 after immunization. (L-M) Number (#) of Tet+ CD8+ T cells expressing CD69±CD103 in IST were enumerated on (L) d30 or (M) d60 after immunization. Data are mean ± SEM, with n = 3–6 per group, and representative of two independent experiments. Immunization dose: 25 μg NP, 9.5 μg Flu, 1.4 μg CpG. Limit of detection: 1 cell (AW), 5 cells (IST/MV), 25 cells (spleen). *p<0.05, **p<0.01, ***p<0.001, by (B-I) ordinary one-way ANOVA or (J-M) ordinary two-way ANOVA with Tukey’s multiple comparisons test. ns, not significant.

Article Snippet: In experiments evaluating tissue-resident memory markers on d30 and d60, cells from lungs and spleens were also stained with anti-CD69-PE/Cy7 (clone H1.2F3; Tonbo), anti-CD103-Brilliant Violet 510 (clone 2E7; BioLegend), and anti-CXCR3-PerCP/Cy5.5 (clone CXCR3–173; BioLegend).

Techniques: Marker, Staining, Expressing